| [1] |
You B, Pan S, Gu M, et al. Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation[J].Extracell Vesicles, 2022,11:e12221.doi: 10.1002/jev2.12221.
|
| [2] |
Campanacci V, Urvoas A, Ammar Khodja L, et al. Structural convergence for tubulin binding of CPAP and vinca domain microtubule inhibitors[J]. Proc Natl Acad Sci USA,2022,119:e2120098119. doi:10.1073/pnas.2120098119.
|
| [3] |
Jiang J, Zhang H, Wang C, et al. 1-Phenyl-dihydrobenzoindazoles as novel colchicine site inhibitors: struc-tural basis and antitumor efficacy[J]. Eur J Med Chem,2019,177:448-456.
|
| [4] |
Chen H, Deng S, Wang Y, et al. Structure-activity relationship study of novel 6-Aryl-2-benzoyl-pyridines as tubulin polymerization inhibitors with potent antiprolifera-tive properties[J]. Med Chem,2020,63:827-846.
|
| [5] |
Yao Y, Huang T, Wang Y, et al. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors[J]. J Enzyme Inhib Med Chem,2022,37:652-665.
|
| [6] |
Agut R, Falomir E, Murga J, et al. Synthesis of combretastatin A-4 and 3'-aminocombretastatin A-4 derivatives with aminoacid containing pendants and study of their interaction with tubulin and as downregulators of the VEGF, hTERT and c-Myc gene expression[J]. Molecules,2020,25. doi: 10.3390/molecules25030660.
|
| [7] |
Gold M, Köhler L, Lanzloth C, et al. Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones[J].Eur J Med Chem,2020,189:112060.doi: 10.1016/j.ejmech.2020.112060.
|
| [8] |
Sung SJ, Kim HK, Hong YK, et al. Autophagy is a potential target for enhancing the anti-angiogenic effect of mebendazole in endothelial cells[J].Biomol Ther (Seoul),2019,27:117-125.
|
| [9] |
Wang M, Zhang C, Zheng Q, et al. RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways[J].Int J Biol Sci, 2022,18:942-955]
|
| [10] |
Sun M, Zhang Y, Qin J, et al. Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization[J].Bioorg Chem,2021,113:104988. doi:10.1016/j.bioorg.2021.104988.
|
| [11] |
Sun M, Wang Y, Yuan M, et al. Angiogenesis, anti-tumor, and anti-metastatic activity of novel α-substituted hetero-aromatic chalcone hybrids as inhibitors of microtubule polymerization[J]. Front Chem, 2021,9:766201.doi: 10.3389/fchem.2021.766201.
|
| [12] |
Wang Y, Sun M, Wang Y, et al. Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency[J]. Eur J Med Chem,2021,225:113790. doi: 10.1016/j.ejmech.2021.113790.
|
| [13] |
Fan A, Wei J, Yang M, et al. Pharmacodynamic and pharmacokinetic characteristics of YMR-65, a tubulin inhibitor, in tumor-bearing mice[J]. Eur J Pharm Sci,2018,121:74-84.
|
| [14] |
Huang H, Yao Y, Hou G, et al. Design, synthesis and biological evaluation of tanshinone IIA-based analogues: potent inhibitors of microtubule formation and angiogenesis[J]. Eur J Med Chem,2021,224:113708. doi: 10.1016/j.ejmech.2021.113708.
|
| [15] |
Nie W, Wang B, Mi X, et al. Co-delivery of paclitaxel and shMCL-1 by folic acid-modified nonviral vector to overcome cancer chemotherapy resistance[J]. Small Methods,2021,5:e2001132. doi: 10.1002/smtd.202001132.
|
| [16] |
Elhemely MA, Belgath AA, El-Sayed S, et al. SAR of novel 3-arylisoquinolinones: meta-Substitution on the Aryl ring dramatically enhances antiproliferative activity through binding to microtubules[J].J Med Chem,2022,65:4783-4797.
|
| [17] |
Sun M, Qin J, Kang Y, et al. 2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response[J].Bioorg Chem, 2022, 120: 105625. doi: 10.1016/j.bioorg.2022.105625.
|
| [18] |
Porcu E, Persano L, Ronca R, et al. The novel antitu-bulin agent TR-764 strongly reduces tumor vasculature and inhibits HIF-1alpha activation[J].Sci Rep, 2016: 6: 27886. doi: 10.1038/srep27886.
|
| [19] |
Xu L, Wang W, Meng T, et al. New microtubulin inhi-bitor MT189 suppresses angiogenesis via the JNK-VEGF/VEGFR2 signaling axis[J]. Cancer Lett,2018,416:57-65.
|
| [20] |
Cao Y, Wang J, Tian H, et al. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer[J]. Exp Clin Cancer Res,2020,39:119. doi: 10.1186/s13046-020-01621-y.
|
| [21] |
Macabrey D, Longchamp A, MacArthur MR, et al. Sodium thiosulfate acts as a hydrogen sulfide mimetic to prevent intimal hyperplasia via inhibition of tubulin polymerisation[J]. EBioMedicine, 2022,78:103954. doi: 10.1016/j.ebiom.2022.103954.
|
| [22] |
Izumi Y, Aoshima K, Hoshino Y, et al. Effects of combretastatin A-4 phosphate on canine normal and tumor tissue-derived endothelial cells[J]. Res Vet Sci, 2017,112:222-228.
|
| [23] |
Yang M, Su Y, Wang Z, et al. C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma[J]. Biochem Pharmacol,2021,190:114641. doi: 10.1016/j.bcp.2021.114641
|
| [24] |
Belzacq-Casagrande AS, Bachelot F, De Oliveira C, et al. Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor[J]. Invest New Drugs,2013,31:304-319.
|
